Our Services
Medical Information
Helpful Resources
Published on: 11/9/2026
Negative celiac blood tests do not always rule out celiac disease, because roughly 1 to 2 percent of people have seronegative celiac disease, meaning they show villous atrophy and intestinal damage on biopsy despite normal tTG-IgA and EMA results. Common reasons include IgA deficiency, already following a gluten-free diet before testing, young age, early or mild disease, immunosuppressant use, and lab or testing errors, while look-alike conditions such as autoimmune enteropathy, Crohn's disease, giardia, SIBO, and common variable immunodeficiency must also be excluded. Diagnosis usually relies on duodenal biopsy, total IgA measurement, HLA-DQ2/DQ8 genetic testing, and documented response to a gluten-free diet. There are several important details and testing pitfalls to consider, so see below to understand more before accepting a negative result as final.
If you have ongoing diarrhea, bloating, weight loss, anemia, or fatigue that normal blood work has not explained, a free, instant, online symptom check can help you organize your symptoms, see which conditions may fit your pattern, and decide what to ask your doctor next.
Last reviewed for medical accuracy: 11/09/2026
Celiac disease is an autoimmune condition in which eating gluten triggers the immune system to damage the small intestine. Gluten is found in wheat, barley, and rye. Over time, this inflammation can flatten the tiny, finger-like structures called villi, which help the body absorb nutrients.
Many people associate celiac disease with positive blood tests. However, a small number of people have intestinal damage consistent with celiac disease even though standard blood work is negative. This is known as seronegative celiac disease.
A negative blood test does not automatically rule out celiac disease, especially when symptoms, risk factors, or an intestinal biopsy suggest otherwise. At the same time, intestinal damage can have causes other than celiac disease, so diagnosis usually requires a careful medical evaluation.
“Seronegative” means that blood tests did not detect the celiac-related antibodies doctors usually look for. The most commonly used test is the tissue transglutaminase immunoglobulin A test, often called tTG-IgA. Doctors may also use an endomysial antibody test, or EMA, and deamidated gliadin peptide antibodies, or DGP.
These tests are useful, but no test is perfect. In most people with celiac disease, antibody levels rise in response to gluten. In a minority, the immune response in the blood is not strong enough to produce detectable antibodies, even when the small intestine is affected.
Seronegative celiac disease is considered uncommon. It should not be diagnosed solely because someone has digestive symptoms and a negative blood test. Doctors typically look for several pieces of evidence, including intestinal biopsy findings, symptoms, nutritional problems, genetic testing, and improvement after a medically supervised gluten-free diet.
Several factors can explain negative celiac blood work despite intestinal damage.
The most common celiac antibody test, tTG-IgA, depends on the immune protein immunoglobulin A, or IgA. Some people have selective IgA deficiency, an inherited immune-system variation that is more common in people with celiac disease than in the general population.
If a person does not make enough IgA, a tTG-IgA test may be falsely negative. For this reason, doctors often order a total IgA test at the same time. If IgA is low, IgG-based tests, such as tTG-IgG or DGP-IgG, may be more useful.
Celiac blood tests and biopsies are most reliable when a person is regularly eating gluten. If you have already reduced or eliminated bread, pasta, cereals, or other gluten-containing foods, antibody levels may fall and the intestine may begin to heal.
This can lead to negative results even if celiac disease was the original cause of the damage. Do not deliberately restart gluten without discussing it with a doctor, particularly if you have severe symptoms or significant nutritional deficiencies. A clinician can explain whether a gluten challenge is appropriate and how it should be done.
Antibody levels can be lower in people with early or less extensive celiac disease. Some people have clear intestinal changes but little antibody production in the bloodstream. This may happen because the immune response is concentrated in the intestinal lining rather than circulating throughout the body.
Laboratory tests vary in performance, and results can be affected by the specific assay used, the severity of disease, and individual immune responses. A negative result lowers the likelihood of celiac disease, but it does not make the condition impossible.
When celiac disease remains a concern, a doctor may use several types of testing.
A biopsy showing villous damage is important, but it is not specific to celiac disease. Doctors must also consider infections, medications, inflammatory bowel disease, autoimmune disorders, common variable immune deficiency, and other intestinal conditions.
If blood tests are negative and a biopsy shows intestinal injury, doctors may investigate other possibilities, including:
This is why it is important not to assume that every case of villous atrophy is celiac disease. The correct diagnosis determines the right treatment.
Celiac disease can cause digestive symptoms, but some people have few or no stomach-related complaints. Possible symptoms include:
Symptoms can overlap with irritable bowel syndrome, lactose intolerance, thyroid disease, and other conditions. If you are unsure how concerning your symptoms may be, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It cannot diagnose celiac disease, but it may help you organize information before speaking with a clinician.
Start by speaking with a doctor, gastroenterologist, or other qualified healthcare professional. Bring a list of symptoms, medical conditions, medications, dietary changes, and relevant family history. Tell the doctor if you have already stopped eating gluten, because this can change test results.
Avoid starting a strict gluten-free diet before medical evaluation unless a healthcare professional advises you to do so. Removing gluten too early can make both blood tests and biopsies harder to interpret. If celiac disease is confirmed, a dietitian experienced in celiac care can help you avoid hidden sources of gluten and maintain adequate fiber, vitamins, and minerals.
Treatment for confirmed celiac disease is a lifelong, strict gluten-free diet. Follow-up is important because symptoms may improve before the intestine has fully healed. Doctors may monitor antibody levels, nutritional status, bone health, and ongoing symptoms. If the diagnosis is uncertain, continued symptoms on a gluten-free diet should prompt reassessment rather than simply removing more foods.
Negative celiac blood work is reassuring, but it is not an absolute rule-out. Seronegative celiac disease can occur, particularly when there is IgA deficiency, limited gluten exposure, early disease, or a biopsy showing characteristic intestinal changes.
However, intestinal damage has several possible causes. The safest approach is a structured evaluation that combines blood tests, biopsy findings, genetic testing, symptoms, and medical history. Speak to a doctor about symptoms that are persistent, worsening, or potentially serious. Seek urgent medical care for severe dehydration, vomiting that will not stop, black or bloody stools, fainting, severe abdominal pain, breathing difficulty, or any symptom that could be life-threatening.
(References)
* Holden W, Orchard T, Wordsworth P. Enteropathic arthritis. Rheum Dis Clin North Am. 2003 Aug;29(3):513-30, viii. doi: 10.1016/s0889-857x(03)00043-7. PMID: 12951865.
* Husby S, Murray JA, Katzka DA. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review. Gastroenterology. 2019 Mar;156(4):885-889. doi: 10.1053/j.gastro.2018.12.010. Epub 2018 Dec 19. PMID: 30578783; PMCID: PMC6409202.
* Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, Mulder CJ, Lundin KEA. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613. doi: 10.1177/2050640619844125. Epub 2019 Apr 13. PMID: 31210940; PMCID: PMC6545713.
* Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, Fasano A. Celiac disease: a comprehensive current review. BMC Med. 2019 Jul 23;17(1):142. doi: 10.1186/s12916-019-1380-z. Epub 2019 Jul 23. PMID: 31331324; PMCID: PMC6647104.
* Calado J, Verdelho Machado M. Celiac Disease Revisited. GE Port J Gastroenterol. 2022 Mar;29(2):111-124. doi: 10.1159/000514716. Epub 2021 Mar 17. PMID: 35497669; PMCID: PMC8995660.
* Lenti MV, Rossi CM, Melazzini F, Gastaldi M, Bugatti S, Rotondi M, Bianchi PI, Gentile A, Chiovato L, Montecucco C, Corazza GR, Di Sabatino A. Seronegative autoimmune diseases: A challenging diagnosis. Autoimmun Rev. 2022 Sep;21(9):103143. doi: 10.1016/j.autrev.2022.103143. Epub 2022 Jul 15. PMID: 35840037.
* Lega S, De Leo L, Ziberna F, Grigoletto V, Gaita B, Giangreco M, Villanacci V, Bramuzzo M, Di Leo G, Not T. Rapid Immunochromatography on Fresh Intestinal Biopsy Is Highly Accurate in Detecting Intestinal Antitransglutaminase Antibodies. Am J Gastroenterol. 2023 Apr 1;118(4):738-743. doi: 10.14309/ajg.0000000000002105. Epub 2022 Dec 23. PMID: 36629801; PMCID: PMC10045964.
* Simón E, Molero-Luis M, Fueyo-Díaz R, Costas-Batlle C, Crespo-Escobar P, Montoro-Huguet MA. The Gluten-Free Diet for Celiac Disease: Critical Insights to Better Understand Clinical Outcomes. Nutrients. 2023 Sep 16;15(18). doi: 10.3390/nu15184013. Epub 2023 Sep 16. PMID: 37764795; PMCID: PMC10537989.
* Al-Toma A, Zingone F, Branchi F, Schiepatti A, Malamut G, Canova C, Rosato I, Ocagli H, Trott N, Elli L, Popp A, Gianfrani C, Auricchio R, Neefjes-Borst A, Sanders DS, Cellier C, Mulder CJ, Bouma G, Lundin KEA, Sollid LM, Schumann M. European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach. United European Gastroenterol J. 2025 Dec;13(10):1855-1886. doi: 10.1002/ueg2.70119. Epub 2025 Sep 26. PMID: 40999951; PMCID: PMC12704582.
* Bouma G, Mulder CJ, Cellier C. Complicated Celiac Disease: Refractory Celiac Disease and Seronegative Villous Atrophy Spectrum. Gastrointest Endosc Clin N Am. 2025 Oct;35(4):823-838. doi: 10.1016/j.giec.2025.02.009. Epub 2025 Jul 1. PMID: 41107015.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.